RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationUpdates on the ACT EU initiative, CTIS and the clinical trials landscape in the EU
Latest updates on medicine and medical device safety from the MHRA.
New digital expertise aims to strengthen how medicines and devices are regulated in the UK.
Guidance clarifies GMP expectations for diagnostic radiopharmaceuticals used in clinical trials.
Updated GCP guidance aligned with ICH E6 is now officially in force for UK clinical trials.
UK government announces major reforms to improve the speed and efficiency of clinical trials.
Guidance outlines how and when to report serious breaches in clinical trials.
MHRA shares findings from its pilot to improve how substantial clinical trial modifications are handled.
A new OpenAI model aims to speed up biology and drug development research while keeping scientists firmly in control.
Insights from the National AI Commission addressing key questions on AI’s future in the UK.